Company comparison
Axelera AI vs Cadence Design Systems
Radar profile, momentum bars, and stack placement side by side.
Axelera AI
Not scored
momentum
Cadence Design Systems
Not scored
momentum
Axelera AI capital
—
Cadence Design Systems capital
—
No radar series.
Momentum head-to-head
Attribute tape
| Field | Axelera AI | Cadence Design Systems |
|---|---|---|
| Category | Semiconductors and hardware | Semiconductors and hardware |
| Stack | Layer 1 | Layer 1 |
| HQ | Eindhoven, Netherlands | San Jose, CA, United States |
| Founded | 2021 | 1988 |
| Status | Operating | Operating |
| Funding | — | — |
| Momentum | — | — |
| Summary | Axelera AI is a European AI semiconductor company designing hardware and software for efficient edge AI inference. Its Metis platform combines proprietary Digital In-Memory Compute (D-IMC) architecture with RISC-V dataflow cores to deliver high-throughput, low-power AI acceleration for computer vision and generative AI workloads at the edge. | Cadence Design Systems is a leading provider of electronic design automation (EDA) software, hardware-assisted verification, semiconductor IP, and AI-driven system design tools used to create chips, PCBs, and complex electronic systems. It also extends its computational intelligence platform into molecular sciences for drug discovery. |
| Who for | Teams evaluating AI vendors in this category. | Teams evaluating AI vendors in this category. |
| Differentiator | Axelera AI is a European AI semiconductor company designing hardware and software for efficient edge AI inference. Its Metis platform combines proprietary Digital In-Memory Compute (D-IMC) architecture with RISC-V dataflow cores to deliver high-throughput, low-power AI acceleration for computer vision and generative AI workloads at the edge. | Cadence Design Systems is a leading provider of electronic design automation (EDA) software, hardware-assisted verification, semiconductor IP, and AI-driven system design tools used to create chips, PCBs, and complex electronic systems. It also extends its computational intelligence platform into molecular sciences for drug discovery. |